-
Home
-
Product
-
IMMUNOHISTOCHEMISTRY
-
INSTRUMENT
-
MOLECULAR
-
HISTOLOGY
-
CYTOLOGY
-
DIGITAL PATHOLOGY
-
-
Solution
-
Support
-
About
-
Contact
PRODUCT CATEGORY
CONTACT US
Phone
Email
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
DLEU Gene Deletion Detection Kit
Clinic Signification：
1.13q14 (DLEU gene) homozygous or heterozygous deletion is the most common abnormality in CLL (more than 60%), and the incidence rate in MM is 16-40%. The prognosis is poor.
2.DLEU gene deletion can also be seen in the detection of MAF/IGH fusion genes in tumors such as lymphoma/myeloma/prostate cancer/head and neck cancer/non-small cell lung cancer.
Chat
message
Quote
Contrast
DLEU Normal
DLEU Deletion
More Info
Probe Description: GSP DLEU /CSP13
Cat.No.: CF1270
Specification: 10 tests/box, 20 tests/box
Related Product
